Transgene
Transgene is a clinical-stage biotechnology company focused on designing and developing novel immunotherapeutics. Every day, we push the boundaries of innovation with our therapeutic vaccines and oncolytic viruses, to design better treatments for patients. We participate in exchanges and collaborations with the aim of developing our R&D expertise, our product portfolio, and our processes. Transgene is engaged in several collaborative programs with public and private partners, in France and worldwide.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
About us
Our approach uses the mechanisms of the immune response to enable the patient’s body to fight against disease. At Transgene, we integrate genetic sequences (or transgenes) into viral vectors to transform them into weapons that can kill abnormal cells.
Transgene’s immunotherapeutics can be administered as single agents or in combination with other treatments (immunotherapy, chemotherapy, etc.).